Affimed N.V. (AFMD) stock Forecast for 2022 – 2026
Last update: February 7, 2023 (07:55)
Sector: HealthcareThe share price of Affimed N.V. (AFMD) now
50/200 Day Moving Average: $1.486 / $2.431
This figure corresponds to the Average Price over the previous 50/200 days. For Affimed N.V. stocks, the 50-day moving average is the resistance level today.
For Affimed N.V. stocks, the 200-day moving average is the resistance level today.
Are you interested in Affimed N.V. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Affimed N.V. stock price in 2023, 2024, 2025, 2026, 2027. How much will one Affimed N.V. share be worth in 2023 - 2027?
When should I take profit in Affimed N.V. stock? When should I record a loss on Affimed N.V. stock? What are analysts' forecasts for Affimed N.V. stock? What is the future of Affimed N.V. stock? We forecast Affimed N.V. stock performance using neural networks based on historical data on Affimed N.V. stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Affimed N.V. stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Affimed N.V. shares. This happens once a day.
Historical and forecast chart of Affimed N.V. stock
The chart below shows the historical price of Affimed N.V. stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Affimed N.V. stock price can be found in the table below.
Long-term forecasts by years.
Affimed N.V. daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb 09 | 1.17 | 1.14 | 1.18 | 3.32 |
| Feb 10 | 1.18 | 1.16 | 1.20 | 3.32 |
| Feb 11 | 1.19 | 1.16 | 1.20 | 3.20 |
| Feb 12 | 1.17 | 1.15 | 1.18 | 2.23 |
| Feb 13 | 1.16 | 1.14 | 1.18 | 3.51 |
| Feb 14 | 1.14 | 1.12 | 1.17 | 4.37 |
| Feb 15 | 1.14 | 1.13 | 1.16 | 2.27 |
| Feb 16 | 1.14 | 1.11 | 1.16 | 4.01 |
| Feb 17 | 1.16 | 1.13 | 1.17 | 3.97 |
| Feb 18 | 1.14 | 1.13 | 1.16 | 2.29 |
| Feb 19 | 1.12 | 1.11 | 1.14 | 2.85 |
| Feb 20 | 1.15 | 1.14 | 1.18 | 3.07 |
| Feb 21 | 1.15 | 1.13 | 1.17 | 4.22 |
| Feb 22 | 1.16 | 1.13 | 1.19 | 4.78 |
| Feb 23 | 1.14 | 1.14 | 1.16 | 1.74 |
| Feb 24 | 1.14 | 1.11 | 1.14 | 3.08 |
| Feb 25 | 1.13 | 1.10 | 1.15 | 4.52 |
| Feb 26 | 1.15 | 1.12 | 1.17 | 3.80 |
| Feb 27 | 1.13 | 1.11 | 1.16 | 4.74 |
| Feb 28 | 1.11 | 1.10 | 1.14 | 3.09 |
| Mar 01 | 1.13 | 1.11 | 1.15 | 3.56 |
| Mar 02 | 1.11 | 1.10 | 1.14 | 3.22 |
| Mar 03 | 1.14 | 1.12 | 1.16 | 3.91 |
| Mar 04 | 1.13 | 1.12 | 1.14 | 2.45 |
| Mar 05 | 1.11 | 1.09 | 1.13 | 3.61 |
| Mar 06 | 1.10 | 1.07 | 1.11 | 3.91 |
| Mar 07 | 1.11 | 1.10 | 1.12 | 2.20 |
| Mar 08 | 1.12 | 1.12 | 1.14 | 2.13 |
| Mar 09 | 1.11 | 1.08 | 1.13 | 3.93 |
| Mar 10 | 1.08 | 1.06 | 1.10 | 3.62 |
Affimed N.V. Daily Price Targets
Affimed N.V. Stock Forecast 02-09-2023.
Forecast target price for 02-09-2023: $1.17.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 3.210%.
Pessimistic target level: 1.14
Optimistic target level: 1.18
Affimed N.V. Stock Forecast 02-10-2023.
Forecast target price for 02-10-2023: $1.18.
Positive dynamics for Affimed N.V. shares will prevail with possible volatility of 3.211%.
Pessimistic target level: 1.16
Optimistic target level: 1.20
Affimed N.V. Stock Forecast 02-11-2023.
Forecast target price for 02-11-2023: $1.19.
Positive dynamics for Affimed N.V. shares will prevail with possible volatility of 3.103%.
Pessimistic target level: 1.16
Optimistic target level: 1.20
Affimed N.V. Stock Forecast 02-12-2023.
Forecast target price for 02-12-2023: $1.17.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 2.182%.
Pessimistic target level: 1.15
Optimistic target level: 1.18
Affimed N.V. Stock Forecast 02-13-2023.
Forecast target price for 02-13-2023: $1.16.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 3.387%.
Pessimistic target level: 1.14
Optimistic target level: 1.18
Affimed N.V. Stock Forecast 02-14-2023.
Forecast target price for 02-14-2023: $1.14.
Negative dynamics for Affimed N.V. shares will prevail with possible volatility of 4.188%.
Pessimistic target level: 1.12
Optimistic target level: 1.17
AFMD (AFMD) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar. | 1.22 | 1.17 | 1.26 | 7.27 |
| Apr. | 1.16 | 1.05 | 1.22 | 13.63 |
| May. | 1.09 | 1.04 | 1.13 | 7.61 |
| Jun. | 1.00 | 0.96 | 1.07 | 10.37 |
| Jul. | 1.02 | 0.95 | 1.09 | 13.16 |
| Aug. | 1.02 | 0.95 | 1.05 | 9.66 |
| Sep. | 1.03 | 1.00 | 1.09 | 8.57 |
| Oct. | 1.00 | 0.96 | 1.04 | 7.60 |
| Nov. | 1.00 | 0.96 | 1.03 | 6.75 |
| Dec. | 1.08 | 1.04 | 1.18 | 11.45 |
Affimed N.V. forecast for this year
Affimed N.V. Stock Prediction for Mar 2023
An uptrend is forecast for this month with an optimal target price of $1.21666. Pessimistic: $1.17. Optimistic: $1.26
Affimed N.V. Stock Prediction for Apr 2023
An downtrend is forecast for this month with an optimal target price of $1.15534. Pessimistic: $1.05. Optimistic: $1.22
Affimed N.V. Stock Prediction for May 2023
An downtrend is forecast for this month with an optimal target price of $1.08602. Pessimistic: $1.04. Optimistic: $1.13
Affimed N.V. Stock Prediction for Jun 2023
An downtrend is forecast for this month with an optimal target price of $1.00131. Pessimistic: $0.96. Optimistic: $1.07
Affimed N.V. Stock Prediction for Jul 2023
An uptrend is forecast for this month with an optimal target price of $1.02054. Pessimistic: $0.95. Optimistic: $1.09
Affimed N.V. Stock Prediction for Aug 2023
An uptrend is forecast for this month with an optimal target price of $1.02176. Pessimistic: $0.95. Optimistic: $1.05
Affimed N.V. Stock Prediction for Sep 2023
An uptrend is forecast for this month with an optimal target price of $1.02544. Pessimistic: $1.00. Optimistic: $1.09
Affimed N.V. Stock Prediction for Oct 2023
An downtrend is forecast for this month with an optimal target price of $0.999597. Pessimistic: $0.96. Optimistic: $1.04
Affimed N.V. Stock Prediction for Nov 2023
An uptrend is forecast for this month with an optimal target price of $1.0032. Pessimistic: $0.96. Optimistic: $1.03
Affimed N.V. Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $1.08145. Pessimistic: $1.04. Optimistic: $1.18
Affimed N.V. (AFMD) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.06 | 0.99 | 1.14 | 12.76 |
| Feb | 1.05 | 1.02 | 1.14 | 10.77 |
| Mar | 1.00 | 0.93 | 1.03 | 9.64 |
| Apr | 1.09 | 1.01 | 1.15 | 12.33 |
| May | 1.19 | 1.07 | 1.29 | 16.42 |
| Jun | 1.29 | 1.24 | 1.38 | 10.70 |
| Jul | 1.35 | 1.31 | 1.38 | 5.27 |
| Aug | 1.41 | 1.31 | 1.49 | 11.81 |
| Sep | 1.45 | 1.36 | 1.51 | 10.34 |
| Oct | 1.44 | 1.41 | 1.49 | 5.35 |
| Nov | 1.39 | 1.32 | 1.51 | 12.20 |
| Dec | 1.38 | 1.33 | 1.51 | 11.93 |
Affimed N.V. (AFMD) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.31 | 1.27 | 1.40 | 9.11 |
| Feb | 1.39 | 1.34 | 1.43 | 6.31 |
| Mar | 1.36 | 1.25 | 1.45 | 13.41 |
| Apr | 1.43 | 1.37 | 1.49 | 8.18 |
| May | 1.55 | 1.48 | 1.60 | 7.43 |
| Jun | 1.50 | 1.42 | 1.61 | 11.32 |
| Jul | 1.37 | 1.28 | 1.41 | 9.40 |
| Aug | 1.33 | 1.24 | 1.41 | 11.89 |
| Sep | 1.39 | 1.27 | 1.45 | 12.77 |
| Oct | 1.35 | 1.25 | 1.42 | 12.01 |
| Nov | 1.49 | 1.44 | 1.52 | 5.39 |
| Dec | 1.58 | 1.52 | 1.64 | 7.32 |
Affimed N.V. (AFMD) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.56 | 1.48 | 1.60 | 7.50 |
| Feb | 1.68 | 1.58 | 1.81 | 12.77 |
| Mar | 1.79 | 1.70 | 1.92 | 11.31 |
| Apr | 1.94 | 1.81 | 2.00 | 9.65 |
| May | 1.83 | 1.66 | 1.99 | 16.62 |
| Jun | 1.90 | 1.81 | 1.95 | 7.45 |
| Jul | 1.69 | 1.57 | 1.81 | 13.72 |
| Aug | 1.69 | 1.60 | 1.77 | 9.84 |
| Sep | 1.73 | 1.61 | 1.80 | 10.71 |
| Oct | 1.81 | 1.67 | 1.91 | 12.93 |
| Nov | 1.93 | 1.88 | 1.98 | 5.03 |
| Dec | 1.98 | 1.85 | 2.08 | 11.27 |
Affimed N.V. (AFMD) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.12 | 2.03 | 2.20 | 7.73 |
| Feb | 2.21 | 2.11 | 2.39 | 11.54 |
| Mar | 2.14 | 1.99 | 2.25 | 11.49 |
| Apr | 2.22 | 2.10 | 2.31 | 9.22 |
| May | 2.28 | 2.08 | 2.49 | 16.46 |
| Jun | 2.00 | 1.85 | 2.20 | 15.99 |
| Jul | 1.90 | 1.73 | 2.01 | 14.05 |
| Aug | 1.97 | 1.82 | 2.12 | 14.17 |
| Sep | 1.95 | 1.81 | 2.04 | 11.46 |
| Oct | 2.04 | 1.94 | 2.17 | 10.61 |
| Nov | 2.17 | 2.05 | 2.32 | 11.74 |
| Dec | 2.11 | 1.93 | 2.31 | 16.48 |
Affimed N.V. information and performance
Affimed N.V., a clinical-stage biopharmaceutical company, is engaged in the discovery and development of immunotherapy treatments for cancer in the United States, Europe and Germany. The lead product candidate is AFM13, which has completed a Phase II clinical trial for CD30-positive T-cell lymphoma and Hodgkin’s lymphoma (HL) and is in Phase II clinical trials for peripheral T-cell lymphoma and transformed fungal mycosis.
IM NEUENHEIMER FELD 582, 69120, HEIDELBERG, DE
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
